Acquired Mutations

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Pfizer to Develop Brain Tumor Treatment with Companion Test from Qiagen's DxS Unit

Published February 10, 2010, 7:45 am, GenomeWeb News

Announcing its second companion diagnostic deal in less than six months, Pfizer last week announced it will work with Qiagen subsidiary DxS to develop a companion test for a brain tumor treatment.

Discover News | Full Story


Autism Speaks: Ten most significant autism research achievements in 2009

Published February 10, 2010, 12:41 am, News-Medical-Net

Autism Speaks, the world's largest autism science and advocacy organization has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year. Every year, Autism Speaks documents the progress made toward its mission to discover the causes and treatment for autism spectrum disorders, and compiles a list of the 10 most significant ...

Discover News | Full Story


DxS acquires exclusive licence for key PI3K gene from Johns Hopkins University

Published February 10, 2010, 12:36 am, PharmaBiz

QIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.

Discover News | Full Story


Top Ten Autism Research Findings Of 2009

Published February 9, 2010, 1:10 pm, redOrbit

Leading Autism Advocacy Organization Documents Progress to Discover Causes and Treatments for Autism Spectrum DisordersAutism Speaks, the world's largest autism science and advocacy organization, has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year. Every year, Autism Speaks documents the progress made toward its mission ...

Discover News | Full Story


Qiagen Obtains License from Johns Hopkins

Published February 9, 2010, 8:24 am, Medical Device Link

Qiagen announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.

Discover News | Full Story


Autism Speaks presents the top ten autism research findings of 2009

Published February 9, 2010, 8:21 am, EurekAlert!

( Autism Speaks ) Autism Speaks, the world's largest autism science and advocacy organization has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year, documenting progress towards the discovery of the causes and treatment for autism spectrum disorders. In 2009 clinical and epidemiological research together with advances in ...

Discover News | Full Story


QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients

Published February 9, 2010, 1:09 am, PharmaceuticalOnline

Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) (Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).

Discover News | Full Story


QIAGEN acquires global licence for PI3K gene to develop real-time-PCR and endpoint PCR assays

Published February 8, 2010, 8:31 pm, News-Medical-Net

QIAGEN today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.

Discover News | Full Story


QIAGEN Acquires Exclusive Licence for Key PI3K gene

Published February 8, 2010, 5:09 pm, redOrbit

VENLO, The Netherlands, February 8 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.

Discover News | Full Story


08.02.2010 - PRESS RELEASE: QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results

Published February 8, 2010, 1:54 pm, 4investors

Qiagen N.V. / QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a